Mirae Asset Global Investments
BCAX

Mirae Asset Global Investments’s Bicara Therapeutics BCAX Stock Holding History

Mirae Asset Global Investments’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.3K Sell
2,939
-366
-11% -$8.17K ﹤0.01% 1262
2026
Q1 		$65.7K Buy
3,305
+643
+24% +$11.1K ﹤0.01% 1245
2025
Q4 		$44.8K Buy
+2,662
New +$45.5K ﹤0.01% 1415

Other funds holding BCAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mirae Asset Global Investments's BCAX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Bicara Therapeutics (BCAX) stake by 11% in Q2 2026, selling an estimated $8.17K and leaving 2,939 shares worth $87.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

Mirae Asset Global Investments first reported a position in BCAX in Q4 2025 and has held it in 3 quarters since. 49 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Mirae Asset Global Investments held 2,939 shares of Bicara Therapeutics worth $87.3K as of Q2 2026.
  • Mirae Asset Global Investments sold 366 Bicara Therapeutics shares in Q2 2026, an estimated $8.17K.
  • Bicara Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1262 holding.
  • Mirae Asset Global Investments first reported a position in Bicara Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 49 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.